Finance

Lists
CSBR:NASDAQ
Champions Oncology Inc
4,76 USD
-1,45%
(-0,070) 1D
5-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSBR...
Open
4,76 USD
High
4,85 USD
Low
4,72 USD
Mkt. cap
66,25 млн
Avg. vol.
9,24 миң
Volume
0,00
52-wk high
8,31 USD
52-wk low
4,63 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,76 USD
High
4,85 USD
Low
4,72 USD
Mkt. cap
66,25 млн
Avg. vol.
9,24 миң
Volume
0,00
52-wk high
8,31 USD
52-wk low
4,63 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
12,00 USD
+152,1%
12/16/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
2026-ж. июл.
Revenue
15,04 млн
16,56 млн
13,84 млн
15,23 млн
Cost of goods sold
7,26 млн
8,83 млн
6,81 млн
7,53 млн
Cost of revenue
7,26 млн
8,83 млн
6,81 млн
7,53 млн
Research and development expenses
2,62 млн
2,27 млн
2,12 млн
2,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,97 млн
5,64 млн
5,43 млн
5,76 млн
Operating expense
7,59 млн
7,91 млн
7,55 млн
8,11 млн
Total operating expenses
14,85 млн
16,75 млн
14,36 млн
15,64 млн
Operating income
185,00 миң
-187,00 миң
-521,00 миң
-409,00 миң
Other non operating income
70,00 миң
39,00 миң
27,00 миң
-6,00 миң
EBT including unusual items
255,00 миң
-237,00 миң
-495,00 миң
-415,00 миң
EBT excluding unusual items
255,00 миң
-148,00 миң
-494,00 миң
-415,00 миң
Income tax expense
18,00 миң
42,00 миң
172,00 миң
11,00 миң
Effective tax rate
7,06%
-17,72%
-34,75%
-2,65%
Other operating expenses
-
-
-
-
Net income
268,00 миң
-279,00 миң
-667,00 миң
-426,00 миң
Net profit margin
1,78%
-1,68%
-4,82%
-2,80%
Earnings per share
0,06
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
542,00 миң
154,00 миң
-200,00 миң
-95,00 миң
Gain or loss from assets sale
-
90,00 миң
1,00 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору